STAT+: Abivax seeks to ease safety concerns with new data, boosting shares
Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago.
But a new analysis sent them climbing.
Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago.
But a new analysis sent them climbing.